SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogelon Mars

Dogelon Mars continues to capture attention as a speculative meme coin, with community sentiment split between frustration over stagnant price action and persistent optimism fueled by hopes for future burns, exchange listings, and ecosystem developments. Investors are actively debating the token's long-term utility versus its status as a high-risk asset, frequently comparing its performance to other major meme coins and major market leaders.

CVR Energy, Inc. is a holding company. The firm engages in the petroleum refining and marketing business. It operates through the following segments: Petroleum, Renewables and Nitrogen Fertilizer. The Petroleum segment refines and markets high value transportation fuels. The Renewables segment includes the operations of the renewable diesel unit. The Nitrogen Fertilizer segment markets nitrogen fertilizers primarily in the form of UAN and ammonia. The company was founded in September 1906 and is headquartered in Sugar Land, TX.

CVR Energy Inc

CVR Energy is trending as investors weigh significant operational setbacks, including recent refinery fires and power outages, against the potential for a rebound driven by high-profile insider accumulation from Carl Icahn. The community is actively debating the company's dividend sustainability and its long-term strategic value in a volatile energy market, with many focused on whether current share prices present an overlooked opportunity or a warning sign.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is facing significant market volatility as investors weigh disappointing early-stage cystic fibrosis clinical data against the company's strong cash position and pipeline potential. Community sentiment remains polarized, with some investors viewing the sharp price decline as an overreaction and a buying opportunity, while others are concerned about the lack of near-term catalysts and long-term commercial viability.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is currently capturing significant attention as investors actively debate its role as a leading meme coin and its potential for recovery following recent price volatility. While some community members are advocating for patient accumulation and long-term holding based on historical performance, others remain skeptical, engaging in heated discussions about the broader risks associated with meme coin cycles and competitive alternatives.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing significant community polarization, as long-term holders continue to emphasize long-term accumulation despite persistent price volatility and skepticism from traders questioning the lack of immediate upward momentum. The conversation centers on technical chart patterns and shifting macro indicators, with retail participants debating whether current levels represent a strategic entry point or a continuation of a downward trend.

Bank of Montreal engages in the provision of banking and financial services to individuals and institutions. It operates through the following segments: Canadian Personal and Commercial Banking (Canadian P&C), United States Personal and Commercial Banking (U.S. P&C), BMO Wealth Management, BMO Capital Markets, and Corporate Services. The company was founded by Robert Armour, John C. Bush, Austin Cuvillier, George Garden, Horatio Gates, James Leslie, George Moffatt, John Richardson and Thomas A. Turner on June 23, 1817 and is headquartered in Toronto, Canada.

Bank of Montreal - MicroSectors Gold Miners -3X Inverse Leveraged ETNs

GDXD is capturing significant trader attention as a high-volatility play for those seeking to hedge or speculate against the relentless upward momentum in precious metals. The community is actively debating the timing of a potential gold correction, with many traders using it as a tactical tool to capitalize on daily swings while others warn of the risks associated with long-term decay in leveraged inverse ETFs.

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ and GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Ideaya Biosciences Inc

Ideaya Biosciences is trending as investors monitor the company's progress toward the highly anticipated Phase 2/3 PFS readout for darovasertib in metastatic uveal melanoma, with the community actively debating whether current low-volume price action reflects institutional accumulation or pre-readout anxiety. While analysts maintain strong conviction in the stock's potential as a future commercial-stage biotech, participants are closely tracking ongoing clinical execution and the broader regulatory outlook for the company's precision medicine oncology pipeline.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies is gaining significant attention as a high-conviction play on the Hyperliquid ecosystem, with investors pointing to its role as a proxy for the native token $HYPE. The community is actively discussing its small float, strong relative strength, and the recent institutional interest from major firms as a catalyst for a potential re-rating.

What is Tron? Tron's mission is to build a truly decentralized internet and aims to be the largest blockchain-based operating system in the world, known as the TRON protocol. The TRON protocol will offer high scalability, high availability, and high throughput computing to serve decentralized applications via smart contracts. Ethereum EVM-based smart contracts will be compatible and deployable on the TRON network as such Solidity developers do not have to rewrite their applications.  Why Tron? Since TRON protocol does not rely on proof of work or mining, instead governed by nodes located around the world, it is decentralized while providing high throughput for transactions on the blockchain. This is suitable for dapps that require high speed transactions especially games. There are a number of tokens already issued on the TRON network and the decentralized exchanges TRX.market has launched.  On July 24th 2018, TRON acquired BitTorrent, one of the largest P2P file sharing protocol. As a result of the acquisition, BitTorrent Token (BTT) was launched as the cryptocurrency to power the economics on the BitTorrent network. The Token will be used to inceltivize file sharing and storage within the network.

Tron

Tron is generating significant community interest driven by its expanding role in global stablecoin transfers and recent strategic cloud partnerships. Investors remain bullish on its long-term network growth, while ongoing discussions focus on its resilience and potential for broader institutional adoption.

abrdn ETF - abrdn Physical Palladium Shares ETF

Investors are closely monitoring PALL as it navigates significant volatility and technical testing, with community discussion heavily focused on its long-term potential amid shifting automotive demand and supply constraints. While many participants debate the timing of a sustainable turnaround, traders are actively looking for confirmation of a technical base as the asset remains a focal point for precious metal diversification.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

JPMorgan Chase & Co. Sells 80,013 Shares of ICU Medical, Inc. $ICUI

JPMorgan Chase & Co. decreased its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 10.6% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 676,370 shares of the medical instruments supplier's stock after selling...

ICU Medical, Inc. $ICUI Shares Purchased by Kennedy Capital Management LLC

Kennedy Capital Management LLC boosted its position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 991.8% during the third quarter, according to its most recent Form 13F filing with...

ICU Medical is Now Oversold (ICUI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...

Segall Bryant & Hamill LLC Reduces Stake in ICU Medical, Inc. $ICUI

Segall Bryant & Hamill LLC lowered its position in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 5.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange...

ICU Medical, Inc. (NASDAQ:ICUI) Given Average Rating of "Moderate Buy" by Brokerages

Shares of ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) have been given an average recommendation of "Moderate Buy" by the five research firms that are presently covering the stock, MarketBeat...

ICU Medical, Inc. $ICUI Shares Sold by Vanguard Group Inc.

Vanguard Group Inc. reduced its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 1.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange...

JPMorgan Chase & Co. trimmed its stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 10.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and...

ICU Medical Q4 Earnings Call Highlights

ICU Medical (NASDAQ:ICUI) reported fourth-quarter 2025 revenue of $536 million and said it delivered 2% organic growth in the period and 5% organic growth for the full year, as management pointed to...

ICU Medical (ICUI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for ICU Medical (ICUI) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

ICU Medical (ICUI) Q4 Earnings and Revenues Surpass Estimates

ICU Medical (ICUI) delivered earnings and revenue surprises of +13.52% and +1.32%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

Current Price	$125.36
Prev Close	$126.63
Open	$125.97
Dividend Yield	0.00%
50-Day Moving Average	$145.75
Beta	1.18
Avg. Volume	309,975.39
PE Ratio	5,095.93

52-Week High	$160.29
52-Week Low	$107.00
Market Capitalization	$3.1B
EPS (Annual)	$0.0294
Price to Book	1.46
Revenue Per Employee	$171,540.39

ICUI
ICU Medical, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ICUI News

ICUIICU Medical, Inc.